214 related articles for article (PubMed ID: 24823996)
21. What is changing in the surgical treatment of gastrointestinal stromal tumors after multidisciplinary approach? A comprehensive literature's review.
DE Simone B; Ansaloni L; Sartelli M; Coccolini F; DI Saverio S; Pantaleo MA; Saponara M; Nannini M; Abongwa HK; Napoli JA; Catena F
Minerva Chir; 2017 Jun; 72(3):219-236. PubMed ID: 28198176
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).
Montemurro M; Cioffi A; Dômont J; Rutkowski P; Roth AD; von Moos R; Inauen R; Toulmonde M; Burkhard RO; Knuesli C; Bauer S; Cassier P; Schwarb H; Le Cesne A; Koeberle D; Bärtschi D; Dietrich D; Biaggi C; Prior J; Leyvraz S
Cancer; 2018 Apr; 124(7):1449-1454. PubMed ID: 29315500
[TBL] [Abstract][Full Text] [Related]
23. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
Kim SJ; Lee SW
J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
[TBL] [Abstract][Full Text] [Related]
24. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
[TBL] [Abstract][Full Text] [Related]
25. Early response evaluation using 18F-FDG-PET/CT does not influence management of patients with metastatic gastrointestinal stromal tumors (GIST) treated with palliative intent.
Farag S; IJzerman NS; Houdijk MPM; Reyners AKL; Arens AI; Grünhagen DJ; Desar IME; Gelderblom H; Steeghs N; de Geus-Oei LF
Nuklearmedizin; 2021 Dec; 60(6):411-416. PubMed ID: 34479374
[TBL] [Abstract][Full Text] [Related]
26. Single-incision laparoscopic surgery for a small-intestinal gastrointestinal stromal tumor: report of a case.
Sakai M; Wada W; Kimura S; Okada A; Hirakata T; Onozato R; Saito K; Morohara K; Osawa H; Katayama K; Yasuda N; Tanaka S; Kuwano H
Int Surg; 2014; 99(4):463-6. PubMed ID: 25058785
[TBL] [Abstract][Full Text] [Related]
27. [Gastrointestinal stromal tumors (GIST)--literature review].
Schöffel N; Groneberg DA; Kaul T; Laatsch D; Thielemann H
MMW Fortschr Med; 2016 Feb; 158(3):60-2. PubMed ID: 27119704
[No Abstract] [Full Text] [Related]
28. Esophageal gastrointestinal stromal tumor: report of 7 patients.
Shinagare AB; Zukotynski KA; Krajewski KM; Jagannathan JP; Butrynski J; Hornick JL; Ramaiya NH
Cancer Imaging; 2012 Apr; 12(1):100-8. PubMed ID: 22542728
[TBL] [Abstract][Full Text] [Related]
29. [Consensus and controversy of surgical diagnosis and treatment for gastrointestinal stromal tumor].
He YL
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):201-3. PubMed ID: 23536334
[TBL] [Abstract][Full Text] [Related]
30. Imaging findings of primary malignant gastrointestinal stromal tumor of the liver.
Kim HO; Kim JE; Bae KS; Choi BH; Jeong CY; Lee JS
Jpn J Radiol; 2014 Jun; 32(6):365-70. PubMed ID: 24682930
[TBL] [Abstract][Full Text] [Related]
31. Preoperative assessment of malignant potential of gastrointestinal stromal tumor by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging: Usefulness of standardized uptake value and retention index.
Kwon Y; Park E; Pahk K; Kim S; Kim MJ; Graf D; Park S
J Cancer Res Ther; 2019; 15(1):142-147. PubMed ID: 30880770
[TBL] [Abstract][Full Text] [Related]
32. Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): recommendations of the German GIST Imaging Working Group.
Kalkmann J; Zeile M; Antoch G; Berger F; Diederich S; Dinter D; Fink C; Janka R; Stattaus J;
Cancer Imaging; 2012 May; 12(1):126-35. PubMed ID: 22572545
[TBL] [Abstract][Full Text] [Related]
33. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
Gayed I; Vu T; Iyer R; Johnson M; Macapinlac H; Swanston N; Podoloff D
J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
[TBL] [Abstract][Full Text] [Related]
34. [Pitfalls and dilemmas in the decision-making process of diagnosis and treatment on gastrointestinal stromal tumor].
Cao H; Wang M
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):823-834. PubMed ID: 32927504
[TBL] [Abstract][Full Text] [Related]
35. Unusual loss of FDG uptake in recurrent GIST.
Dunzinger A; Decker J; Kieberger A; Weis S; Pichler R
Nuklearmedizin; 2014 Aug; 53(4):N35-7. PubMed ID: 25100559
[No Abstract] [Full Text] [Related]
36. [Translational research and diagnosis in GIST].
Wardelmann E
Pathologe; 2012 Nov; 33 Suppl 2():273-7. PubMed ID: 22968735
[TBL] [Abstract][Full Text] [Related]
37. Early Evaluation of Response Using
Farag S; Geus-Oei LF; van der Graaf WT; van Coevorden F; Grunhagen D; Reyners AKL; Boonstra PA; Desar I; Gelderblom H; Steeghs N
J Nucl Med; 2018 Feb; 59(2):194-196. PubMed ID: 28970330
[No Abstract] [Full Text] [Related]
38. Positron emission tomography for prostate, bladder, and renal cancer.
Schöder H; Larson SM
Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
[TBL] [Abstract][Full Text] [Related]
39. Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to
Van Weehaeghe D; Gheysens O; Vandecaveye V; Schöffski P; Van Laere K; Deroose CM
BMC Cancer; 2018 Mar; 18(1):253. PubMed ID: 29506493
[TBL] [Abstract][Full Text] [Related]
40. FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumor.
Basu S; Mohandas KM; Peshwe H; Asopa R; Vyawahare M
Nucl Med Commun; 2008 Dec; 29(12):1026-39. PubMed ID: 18987522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
